300 related articles for article (PubMed ID: 8839552)
1. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
Iczkowski KA; Bai S; Pantazis CG
Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
6. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
9. CD44 Expression in Benign and Neoplastic Human Prostates.
Dhir R; Gau JT; Krill D; Bastacky S; Bahnson RR; Cooper DL; Becich MJ
Mol Diagn; 1997 Sep; 2(3):197-204. PubMed ID: 10462610
[TBL] [Abstract][Full Text] [Related]
10. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
11. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
12. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
Weber B; Rösel M; Arch R; Möller P; Zöller M
Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
14. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
[TBL] [Abstract][Full Text] [Related]
15. De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer.
Paradis V; Eschwège P; Loric S; Dumas F; Ba N; Benoît G; Jardin A; Bedossa P
J Clin Pathol; 1998 Nov; 51(11):798-802. PubMed ID: 10193318
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
18. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
20. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
